Create a tabular difference between 1. Phyllodes tumor and fibroadenoma 2. Benign and malignant breast tumor The content should be based on 2nd mbbs pathology ROBBINS AND COTRANS PATHOGENESIS OF DISEAS 2ND YEAR
Reading File
Finding Sources
Finding Sources
Searching PubMed
phyllodes tumor AND fibroadenoma
Searching the Web
Robbins Cotran Pathologic Basis of Disease breast phyllodes tumor fibroadenoma benign malignant differences
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
1. Phyllodes tumor vs Fibroadenoma
| Feature | Fibroadenoma | Phyllodes tumor |
|---|---|---|
| Nature | Most common benign stromal tumor of the female breast | Uncommon fibroepithelial tumor with benign, borderline, or malignant potential |
| Cell of origin | Intralobular stroma | Intralobular stroma |
| Components | Biphasic lesion: neoplastic stromal component with non-neoplastic epithelial ducts | Biphasic lesion: neoplastic stromal component with epithelial-lined spaces |
| Molecular changes | Commonly has MED12 mutations. Some have RARA mutations. | Often has MED12 and RARA mutations, but is more likely to acquire additional TERT, TP53, and RB mutations. |
| Frequency | Very common | Much less common, about 2.5% of fibroepithelial lesions |
| Usual age | Young women, usually 20-30 years | Usually presents in the sixth decade, about 10-20 years later than fibroadenoma |
| Clinical presentation | Mobile, painless, well-defined palpable lump; can be multiple and bilateral | Usually a palpable mass; may enlarge rapidly and become very large |
| Hormonal response | Hormone responsive: may enlarge during pregnancy and regress after menopause | No comparable typical pregnancy-related growth/regression pattern is emphasized |
| Gross appearance | Well-circumscribed, rubbery, gray-white mass; often small | May range from a few centimeters to a mass replacing most of the breast; larger lesions show bulging nodules |
| Microscopy: stroma | Delicate, often myxoid stroma resembling normal intralobular stroma; low cellularity and low mitotic activity | Increased stromal cellularity and mitotic activity. Borderline and malignant lesions show increasing stromal atypia and stromal overgrowth. |
| Microscopy: epithelial pattern | Pericanalicular pattern: stroma surrounds patent ducts; intracanalicular pattern: compressed ducts form slit-like spaces | Characteristic leaf-like architecture, caused by stromal projections lined by epithelium, often projecting into cystic spaces |
| Margins | Sharply circumscribed and pushing | Benign lesions may be circumscribed; malignant lesions are often widely infiltrative |
| Classification | Benign tumor | Classified as benign, borderline, or malignant, based on stromal histology |
| Recurrence | Generally does not recur after adequate removal | Benign lesions may recur locally; borderline and malignant tumors have a higher local recurrence rate. Margin status is important. |
| Metastasis | Does not metastasize | Benign tumors do not metastasize. Malignant tumors can metastasize hematogenously, in about one-third of cases. |
| Lymph-node spread | Not applicable | Rare even in malignant phyllodes tumor; axillary lymph-node dissection is not indicated routinely |
| Key differentiating point | Uniform, low-cellularity stroma with circumscribed border | More cellular, mitotically active stroma and leaf-like pattern; malignant lesions show atypia, stromal overgrowth, and infiltration |
Exam point: Both are biphasic tumors of intralobular stroma. The most useful histologic distinction is the greater stromal cellularity, atypia, mitotic activity, and leaf-like architecture in phyllodes tumor.
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, Breast chapter, “Fibroadenoma” and “Phyllodes Tumor,” pp. 967-968.
2. Benign vs Malignant Breast Tumors
| Feature | Benign breast tumor | Malignant breast tumor |
|---|---|---|
| Typical examples | Fibroadenoma, lipoma, myofibroblastoma | Invasive breast carcinoma, malignant phyllodes tumor, angiosarcoma |
| Frequency | Fibroadenoma is the most common benign breast tumor | Most breast malignancies are adenocarcinomas |
| Growth rate | Usually slow growing | May grow progressively and rapidly, though rate varies by subtype |
| Gross margins | Usually well-circumscribed, sharply demarcated, often encapsulated or pushing | Commonly irregular, ill-defined, infiltrative margins |
| Consistency | Often soft to rubbery, mobile | Often hard due to desmoplastic stromal reaction; may be fixed |
| Relation to surrounding breast tissue | Compresses or displaces adjacent tissue without destroying it | Invades and destroys adjacent breast tissue |
| Cell differentiation | Cells closely resemble normal mature cells | Variable differentiation; may be well, moderately, or poorly differentiated |
| Cellular atypia | Minimal or absent pleomorphism; nuclei generally uniform | Nuclear pleomorphism, hyperchromasia, increased nuclear-cytoplasmic ratio, and prominent nucleoli may be present |
| Mitoses | Few and typical mitoses | Increased mitotic activity; atypical mitotic figures may be seen |
| Necrosis | Uncommon | More frequent in high-grade malignant tumors |
| Architecture | Preserved and orderly tissue pattern | Disorganized architecture, irregular nests, cords, glands, or sheets of malignant cells |
| Stromal response | Usually little or no desmoplasia | Invasive breast carcinoma commonly evokes desmoplastic stroma, producing a hard, irregular mass |
| Local invasion | Absent | Present. Tumor may infiltrate breast stroma, skin, chest wall, lymphovascular spaces, or nerves. |
| Metastasis | Absent | Can spread to regional lymph nodes and distant organs. Distant metastasis is the most important adverse prognostic factor. |
| Recurrence after excision | Uncommon if completely removed, except for particular lesions | Depends on tumor type, grade, stage, lymph-node status, and adequacy of treatment; recurrence may be local or distant |
| Effect on skin/nipple | Usually no skin or nipple changes | May cause skin dimpling, nipple retraction, peau d’orange, ulceration, or inflammatory changes |
| Prognosis | Excellent | Depends on stage, tumor size, nodal involvement, distant metastasis, histologic grade, and ER/PR/HER2 status |
| Treatment principle | Observation or local excision when indicated | Requires staging and multimodal management, including surgery with or without radiotherapy, systemic endocrine therapy, anti-HER2 therapy, chemotherapy, or immunotherapy depending on subtype |
Important qualification
“Benign” does not always mean completely harmless. For example, benign phyllodes tumor can recur locally, while fibromatosis can be locally infiltrative but does not metastasize. Conversely, malignant behavior is defined chiefly by invasion and capacity for metastasis, not merely by tumor size.
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, Breast chapter, pp. 954-968. Invasive breast carcinoma morphology and grading: pp. 961-965; fibroadenoma and phyllodes tumor: pp. 967-968.
Differentiate diagnosis of palpable breast mass
Reading File
Finding Sources
Finding Sources
Searching PubMed
palpable breast mass diagnosis
Searching the Web
ACR Appropriateness Criteria palpable breast masses diagnostic evaluation 2025
Differential Diagnosis of a Palpable Breast Mass
| Condition | Usual age / setting | Clinical features | Character of mass | Associated findings / clues |
|---|---|---|---|---|
| Fibroadenoma | Common in women aged 20-30 years | Usually painless | Well-circumscribed, firm-rubbery, smooth, highly mobile mass, often called a “breast mouse” | May be multiple or bilateral. Can enlarge in pregnancy and regress after menopause. |
| Phyllodes tumor | Usually 40-60 years | Painless lump with relatively rapid enlargement | Large, well-defined, mobile mass, sometimes with stretched shiny skin due to size | May resemble fibroadenoma clinically. Large size and rapid growth favor phyllodes tumor. Histology is required for confirmation. |
| Breast cyst / fibrocystic change | Usually 35-50 years, often premenopausal | Pain/tenderness often increases before menstruation | Smooth, round or oval, fluctuant, mobile mass | May be multiple. Aspiration yields fluid and causes disappearance of the lump. A residual mass, bloody aspirate, or recurrent cyst needs further evaluation. |
| Carcinoma breast | More frequent after 40 years, risk rises with age | Often painless initially | Hard, irregular, poorly defined, fixed mass | Skin tethering or dimpling, nipple retraction, peau d’orange, ulceration, bloody nipple discharge, or axillary lymphadenopathy may occur. |
| Fat necrosis | History of trauma, surgery, radiation, or anticoagulation may be present | Often painless, sometimes tender | Firm, irregular mass that can be fixed and simulate carcinoma | May show skin retraction and calcification on imaging. Histology may be needed to exclude carcinoma. |
| Acute mastitis / breast abscess | Usually during lactation, especially first month of breastfeeding | Painful, red, warm swollen breast with fever | Ill-defined tender induration; abscess may become fluctuant | Cracked nipple can be a portal of entry. Commonly caused by Staphylococcus aureus. |
| Duct ectasia / periductal mastitis | Perimenopausal women; periductal mastitis often associated with smoking | Pain and subareolar swelling | Tender subareolar mass | Thick, sticky green-brown nipple discharge; nipple retraction may mimic carcinoma. |
| Galactocele | Pregnant or lactating woman, or shortly after stopping breastfeeding | Usually painless | Soft to cystic, mobile mass | Contains milk. Aspiration produces milky fluid. |
| Lipoma | Adults, variable age | Usually asymptomatic | Soft, lobulated, freely mobile mass | Often distinguished by fat density on mammography. |
| Hamartoma | Middle age | Usually asymptomatic | Soft, well-circumscribed mobile mass | “Breast within a breast” appearance on mammography because of mixed fat and glandular tissue. |
| Intraductal papilloma | Usually 35-55 years | Small subareolar lump may or may not be palpable | Usually small and not always felt | Classically causes unilateral spontaneous bloody or serous nipple discharge. |
| Lactating adenoma | Pregnancy or lactation | Painless enlarging mass | Well-defined, mobile mass | Can clinically resemble fibroadenoma. |
| Inflammatory carcinoma | Usually older women | Rapid breast enlargement, heaviness, pain, warmth | A discrete mass may be absent | Diffuse erythema, edema, and peau d’orange due to dermal lymphatic invasion. It can mimic mastitis but does not respond appropriately to antibiotics. |
Important Clinical Differences: Benign vs Malignant Palpable Lump
| Feature | Suggests benign lesion | Suggests malignancy |
|---|---|---|
| Age | Younger woman, especially <30 years | New lump in woman >40 years or postmenopausal woman |
| Margins | Smooth and well-defined | Irregular and ill-defined |
| Mobility | Freely mobile | Fixed to skin, breast tissue, or chest wall |
| Consistency | Soft, rubbery, or cystic | Hard, stony hard, or firm irregular |
| Pain | May be painful or cyclic, especially cyst/mastitis | Usually painless early, though pain does not exclude cancer |
| Skin | Normal | Dimpling, tethering, ulceration, erythema, peau d’orange |
| Nipple | Usually normal | Retraction, deviation, eczematous change, spontaneous bloody discharge |
| Axillary nodes | Usually absent | Hard, enlarged, fixed nodes may be present |
| Course | Stable, cyclic, or regresses | Progressive enlargement or persistent lump |
Diagnostic Approach: Triple Assessment
A palpable breast mass should be assessed by the triple assessment:
-
Clinical assessment
- History: age, duration, pain, menstrual relation, pregnancy/lactation, trauma, nipple discharge, family history, and breast cancer risk factors.
- Examination: inspect both breasts, palpate lump and axillary/supraclavicular nodes.
-
Imaging
- Ultrasound is usually the initial study in women under 30 years, pregnant women, and lactating women.
- In women aged 40 years or older, diagnostic mammography or tomosynthesis, generally followed by targeted ultrasound, is used.
- MRI is not a routine first-line test for a palpable mass. Current ACR guidance supports this age-based imaging approach.
-
Pathological diagnosis
- Core-needle biopsy for a suspicious solid lesion or when clinical and imaging findings do not agree.
- Fine-needle aspiration may help confirm a cyst but core biopsy is preferred for tissue diagnosis of suspected malignancy.
Rule for exams: A lump that is hard, irregular, fixed, associated with skin/nipple changes, or accompanied by axillary lymph nodes should be considered carcinoma until proved otherwise.
Robbins, Cotran & Kumar Pathologic Basis of Disease, Breast chapter: inflammatory disorders pp. 946-947; fibroadenoma and phyllodes tumor pp. 967-968; invasive carcinoma pp. 961-965.
This is a shared conversation. Sign in to Orris to start your own chat.